Accurate as of 8/8/2022: There are 4 patients on Yellow. Daytime for yellow: Both POD 1&2 fellows will be assigned one POD 3 patient each as primary. The role will consist of note writing and primary management during the day until signout to the yellow staff. Both POD 1&2 rounding staff will also be assigned […]
Lung cancer screening eligibility
Eligibility criteria for LCS referral program has been updated and includes the following: The patient is between the ages of 50 – 77 years old Has at least a 20+ pack year smoking history Is a current smoker or Is a former smoker who has quit within the last 15 years Has not had a CT […]
Medical Student Attestations
Here is a recent update on the attestation for staff. Currently MS3 notes are not billable and MS4 notes can be billed. Given the change in schedule best to ask what year the student is as there can be a mix of MS3s and 4s. MS3 inpatient notes: Note TYPE: “Medical/APP Student Note” Currently not billable Staff attestation: .medicalstudenteducationalnote. Residents […]
Pulmonary Rehabilitation Locations
Referring to pulmonary rehab from sterling heights – choose HFN Siville in Epic. This website provides locations of pulmonary rehabilitation centers close to your patient’s home but are not limited to Henry Ford-affiliated.
Post ICU Neuropsychiatric clinic
The Post ICU Neuropsychiatric clinic has lowered their age requirement from 55 to 18. Please see PowerPoint for information on how to refer patients.
Pulmonary Embolism Response Team (PERT) Call
Important Documents PERT Updates May 2026 PERT Algorithm PERT symposium lectures (2/11/2022) Fibrinolysis-risks-and-contraindications Outline of the workflow for PERT Activation: General Overview PERT Activations PERT consultations from outside HFH-Detroit STAT versus Routine Echoes Once a high risk intermediate or massive PE is determined to be in need of a procedure based on hemodynamic, RV strain […]
February is sepsis induced hypoperfusion education month
5 minute video Power point slides for this video
Outpatient Oral COVID-19 Therapies Nirmatrelvir-Ritonavir (Paxlovid) & Molnupiravir
These are not authorized for hospitalized patients Nirmatrelvir-Ritonavir (Paxlovid)Take 2 nirmatrelvir tablets (300 mg) and 1 ritonavir tablet (100 mg) by mouth every 12 hours for 5 days Criteria for use: Positive SARS-CoV-2 test AND• No more than 5 days from symptom onset before initiation AND• Age ≥12 years and weight at least 40 kg […]